ORKA Q4 2019 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$24,000

Operating Income

-$1M

Net Income

-$1M

EPS (Diluted)

$-9.23

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$9M

Total Liabilities

$926,000

Stockholders' Equity

$8M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$24,000	-$5,000	-380.0%
Operating Income	-$1M	-$2M	+16.3%
Net Income	-$1M	-$1M	+17.7%